Intracisternal injection of blood in the rat in duced an angiographically demonstrable biphasic cere bral vasospasm with a maximal acute spasm at 10 min and a maximal late spasm at 2 days after the subarach noid hemorrhage. Systemic administration of 6-hydroxy dopamine, which destroys catecholamine fi bers in the circum ventricular areas characterized by the absence of a blood-brain barrier, prevented the development of both the acute and the late spasm. Isolation or removal of one of the circum ventricular organs, the pituitary, from the
The theory that the hypothalamus is involved in the development of cerebral arterial vasospasm fol lowing a subarachnoid hemorrhage (SAH) has been advocated by Wilkins (1975) . A role for the hypo thalamus in the development of vasospasm is sup ported by the not infrequent occurrence of spasm following craniotomy for intra-or suprasellar tumors, while spasm does not appear following in tracranial surgery not affecting the hypothalamic region (Kagstr6m et aL, 1969; Simeone and Peer less, 1975; Peerless, 1980) . Similarly, the develop ment of vasospasm after a skull trauma, with or without blood in the subarachnoid space, might also be due to damage of the hypothalamus (Wilkins and Odom, 1970; Suwanwela and Suwan wela, 1972; Macpherson and Graham, 1978) . Addi tional evidence for a hypothalamic involvement in brain via a stalk transection or a hypophysectomy did not atl'ect the degree of vasospasm. Lesion of the median em inence, another region without a blood-brain barrier, prevented the development of both types of spasm. The median eminence receives projections from the Al and Az nuclei in the medulla oblongata." It is suggested that the projections of these nuclei to the internal layer of the me dian eminence underlie the development of spasm. Key Words: Blood-brain barrier-6-Hydroxydopamine Median eminence.
spasm is the frequent occurrence of autonomic hy peractivity following SAH or skull trauma (Ham mermeister and Reichenbach, 1969; Offerhaus and Van Gool, 1969; Hawkins and Clower. 1971; Cruickshank et aL, 1974; Neil-Dwyer et aL, 1974; Lacy and Earle, 1983) . Furthermore, Wilson and Feild (1974) found that injection of a hypothalamic extract into the cisterna magna in dogs produced a prolonged cerebral vasospasm.
In a previous communication (Svendgaard et aL. 1985a) , we have shown that ascending catechol amine (CA) pathways projecting to the hypothal amus from the medulla oblongata underlie the de velopment of spasm following an experimental SAH. In the present study we further evaluate the role of the hypothalamus in the development of va sospasm by applying selective lesions in the hypo thalamic-pituitary region to a rat SAH model (Delgado et al.. 1985) .
MATERIALS AND METHODS
The experiments were performed on male Sprague Dawley rats (SPF strain; Mollegaards Avlslaboratorium. Koge, Denmark) weighing between 280 and 350 g.
Anesthesia and surgical procedures
The anesthesia, surgical procedures, and angiography have been thoroughly described and will be briefly sum marized (Delgado et al.. 1985) . After initiation of the an esthesia with 4% halothane, the animals were intubated and artificially ventilated. For the surgical procedure. an esthesia was maintained with 0.75% halothane in a 70% nitrous oxide and 30% oxygen mixture. After infiltrating the skin with lidocaine hydrochloride (Xylocaine): Astra (S6dertalje, Sweden), a catheter was inserted into the ax illary artery bilaterally for subsequent angiography. The femoral artery and vein were cannulated for continuous blood pressure monitoring and for infusion of drugs. Hep arin (75 IU kg-I; Kabi-Vitrum, Stockholm Sweden) was given intravenously. After surgery the halothane was switched off and suxamethonium chloride (Celocurin klorid, 3 mg kg-I i.v.; Kabi-Vitrum, Stockholm. Sweden) was given. Thirty minutes was allowed to pass before an giography.
Angiography
Ve rtebrobasilar angiography was performed via bilat eral axillary catheters using metrizamide (Amipaque: Nyegaard and Co .. Oslo. Norway) as the contrast me dium. The control angiography was fo llowed by the in jection of 0.07 ml of homologous blood intracisternally via a previously implanted catheter connected to the cis terna magna (Delgado et aI., 1985) . Repeat angiography was performed 10 min and/or 2 days after the blood injec tion. the time points of maximal acute and late spasm. respectively, in the rat (Delgado et aI., 1985) . After the angiography on day 0, the catheters were removed. The animals were extubated when awake and returned to their cages. Measurements of the vertebral and basilar arteries were made using a technique similar to that de scribed by Gabrielsen and Greitz (1970) . The diameters were measured with an accuracy of 0.05 mm, which is �5% of the mean vessel diameter. using a calibrated pre cision lens with fi xed magnification and lens-to-film dis tance. The values fr om fo ur preselected points within the vertebrobasilar system were averaged and expressed as percentage of control values. Each animal served as its own control.
Lesions
Systemic 6-Hydroxydo{JaJllinc injectiol1. 6-Hydroxy dopamine (6-0H DA, 100 mg kg-I i.v.) was given to an imals under barbiturate anesthesia (Brietal, 40 mg kg -I i.p.; Lilly, Indianapolis. IN, U.S.A.).
Transection qf the pitllitary stalk. The animals were anesthetized, intubated, and ventilated as described. The surgical approach was that outlined by Porter and Smith (1967) and will be presented briefly. A dissecting Zeiss microscope was used. The animals were placed in a su pine position. Via a midline incision, the soft tissue was retracted until the two capitus longus muscles could be seen. The muscles were scraped off and the basisphenoid bone lying ventral to the pituitary was visualized. Using a dental drill, the pituitary and the stalk were exposed. The stalk was cut with angled scissors where it penetrated the sellar diaphragm and immediately before it joined the pi tuitary (Fig. 1) . The pituitary was removed in about half of the animals. In the remaining animals the pituitary was left in situ and Oxycel cotton (Deseret Medical Inc., Sandy. UT, U.S.A.; Parke Davis and Co., U. S.A.) was inserted into the interspace between the pituitary and the stalk end. In the sham-lesioned animals, the stalk was exposed but no lesion was made.
Median eminence lesion
The median eminence lesion was made either surgi cally or electrothermically using a stereotaxic technique. The approach for the surgical lesion was the same as that described fo r the stalk lesion. By inserting a blunt-tipped hook above the horizontally oriented stalk. the anterior extension of the stalk could be determined. The hook was then replaced by an injection needle no. 20 with the bevel bent 900• From the anterior part of the stalk. the needle was pushed fo rward � I mm until the median eminence was separated fr om the hypothalamus (Fig. I) .
The electrothermic lesions were made using a Ra dionics lesion generator (RF G-4A). The diameter of the electrode was 0.25 mm. It was insulated except fo r the distal 0.25 mm. The animals were anesthetized with Brietal (40 mg kg-I i.p.) and placed in a Kopf stereotaxic fr ame. With the tooth bar at 0, the electrode was inserted 5.1 mm anterior to the interaural line and 0.2 mm fr om the midline bilaterally. After lowering the electrode to the base of the skull, it was elevated 0.3 mm and the lesions produced by raising the temperature of the electrode tip to 67°C for I min (Fig. 2B ). In the sham-lesioned animals, the electrode was lowered to the skull base and then withdrawn.
Control of the lesions
The lesion produced by the intravenous injection of 6-OHDA was controlled by fluorescence microscopy of the irides. 6-0HDA (100 mg kg-I i.v.) produces a chemical sympathectomy that in the iris lasts � 3 weeks (Malmfors and Sachs, 1968) .
The animals with distal stalk transections with or without hypophysectomies were perfused via the axillary artery catheters with I % glutaraldehyde and 2% fo rmal dehyde. After decapitation the soft tissue and bone cov ering the dorsal surface of the brain were removed before storing the specimen in the glutaraldehyde-formalde hyde solution at O°c. In half of the animals, the brain was removed fr om the skull before sectioning, while in the other half. it was kept in situ with the skull bone intact for sectioning. The brain was cut into 20-f,lm sections and stained with hematoxylin-eosin. Microscopy revealed that �0.5 mm of the proximal part of the stalk was left intact and that it contained cells of normal appearance. The basal hypothalamus was undamaged.
The animals with median eminence lesions were pro cessed similarly to the stalk-lesioned animals. The length of the electrothermic lesion was close to 1.4 mm and in cluded 0.4-0.5 mm of the proximal part of the stalk. The width was � I mm and the height at its maximum was also � 1 mm (Fig. 2B ). The lesion extended into the arcuate J Cereh Blood Flow Metab. Vol. 6. No.6, 1986 nuclei. In the animals with surgical lesions, no median eminence tissue was seen, and the damage to the arcuate nuclei was negligible.
In a separate group of six animals, the plasma prolactin level was examined before and 14 days after electro thermic median eminence lesions and showed an increase of �70% in the lesioned animals.
Statistics
The data were analyzed using the Student t test.
Experimental design
There were six experimental groups. The normal an imals were taken fr om an earlier study (Delgado et al., 1985) . The lesions were made 9-14 days prior to the angi ography. The angiography was performed 10 min and/or 2 days after the cisternal blood injection. Some of the le sioned animals were examined at only one time point post SAH, since they tolerated the SAH less well than normal animals. The animals with median eminence and stalk lesions received hydrocortisone (Solu-Cortef, 2 mg i.v.; Upjohn, Kalamazoo, MI. U. S. A.) the day before and the day of implantation of the subcutaneous catheter since their centrally regulated steroid response was missing. The animals also had hydrocortisone (2 mg) the day before angiography and each subsequent day until death. The sham-Iesioned animals also received hydro cortisone. The makeup of the groups was as follows: Group I, six normal animals. Group II, six animals treated with 6-0HDA intravenously. Group III, fo ur normal animals treated with hydrocortisone according to the schedule used for the lesioned animals. Group IV, II animals with pituitary stalk lesions. Six animals also had the pituitary removed. Three of the II were examined at both 10 min and 2 days. The remaining eight were exam ined at either 10 minutes or 2 days post SAH. Group V, nine animals with median eminence lesions (three with surgical and six with electrothermic). Five were exam ined at both time points. The remaining four were exam ined at either 10 min or 2 days. Groups VI, three animals with sham median eminence and three with sham pitu itary stalk lesions. The values from these animals were similar and were therefore pooled.
RESULTS
The physiological parameters in the different ex perimental groups are shown in Ta ble 1. All animals had rectal temperatures close to 37°C. Pao2 was �140 mm Hg; Paco2 was �37 mm Hg; and pH was close to 7. 4. There were no significant differences in the MABP between the experimental groups.
In the four normal animals treated with steroids, the degree of spasm post SAH was similar to that seen in normal SAH animals (mean vessel diameter as percentage of control ± SEM: at 10 min 68.3 ± 6.6% for the steroid-treated group versus 66.4 ± 4. 8% for the normal animals; at 2 days 76. 5 ± 3.5% for the steroid-treated group versus 77.5 ± 6.0% for the normal animals). Also the degree of spasm in the sham-Iesioned animals was similar to that seen in normal animals.
Intravenous 6-0HDA treatment prior to cisternal blood injection prevented the development of vaso- spasm at both 10 min and 2 days post SAH (Fig. 3) .
The baseline mean vessel diameter in the vertebro basilar system was similar to that seen in normal animals.
The animals with stalk lesions had a similar de gree of spasm as the sham-lesioned animals ( Figs. 3  and 4 ). There was no difference in the degree of spasm in the animals with or without the pituitary removed. Sectioning of the stalk did not change the baseline mean vessel diameter.
Lesion of the median eminence prevented the de velopment of both acute and late spasm (Figs. 3 and 5). There was a minor dilatation of the vertebro basilar arteries at both 10 min and 2 days post SAH. The baseline diameter was unchanged. There was no difference in the angiographical findings be tween the surgically or the electrothermicaUy le sioned animals. In an additional two animals not in cluded in the study, the electrothermic lesions were placed 0. 5 instead of 0.3 mm above the base of the skull. Both animals developed acute and late spasm similar to that seen in the sham-Iesioned group. The light microscopical examination of the hypothal amus in these two animals showed no change in the median eminence except for a slight edema in the internal layer (Fig. 2C) . The lesions were localized to the arcuate nuclei.
There was a high mortality ( � 75o/c) in the animals with surgical lesions of the stalk or median emi nence, and the animals included in the statistics represent only a part of a much larger group. The mortality in the animals with electrothermic lesions was much less ( � 15% ) , and there was no mortality in the 6-0HDA-treated animals. The animals devel oping spasm post SAH were drowsy, but did not exhibit focal neurological deficits. The animals not developing spasm seemed unaffected by the CIS ternal blood injection.
DISCUSSION
In a previous communication (Svendgaard et aI., 19850) , it was demonstrated that ascending CA pro jections from the AI and A2 nuclei in the medulla oblongata to the hypothalamus or the pituitary are necessary for the development of vasospasm post SAH. In the present study we have shown that in travenous injection of 6-0HDA or lesion of the me dian eminence prevents the development of vaso spasm post SAH, while caudal pituitary stalk lesion does not affect either the acute or the late spasm.
6-0HDA has a selective destructive effect on CA FIG. 5. Vertebrobasilar angiography in an animal with lesion of the median eminence. Left: Control; Center and Right: 10 min and 2 days, respectively, after cisternal blood injection. No spasm is seen at either 10 minutes or 2 days post subarachnoid hemorrhage.
J Cereb Blood FlOII' Metab. Vo/. 6. No.6. 1986 terminals and axons, leaving neurons contammg other transmitters intact (Tranzer and Thoenen, 1967; Sachs and Jonsson, 1975) . Peripherally, 6-OHDA acts on the sympathetic nervous system (Malmfors, 1971) . After injection of 100 mg 6-OHDA kg-1 i.v., the depletion of noradrenaline (NA) from the nerve terminals starts immediately and is completed within a few hours (Malmfors and Sachs, 1968; de Champlain, 1971) . The regenera tion of the peripheral adrenergic nerve terminals starts within 3-4 days, is extensive at 3 weeks, and is complete after 2-3 months (Finch et aI., 1973; de Champlain et aI., 1975) .
Since 6-0HDA does not penetrate the blood brain barrier (Laverty et aI., 1965) . the central ef fect of the compound is seen in areas not protected by the barrier, such as the median eminence and the posterior and intermediate lobe of the pituitary (Baumgarten et aI., 1972; Jonsson et aI., 1972; Smith and Helme, 1974; Day and Willoughby, 1980; Smith et aI., 1982a; Lim et aI., 1984) , the area pos trema (Brizzee et aI., 1978) , and the subfornical organ . Day and Willoughby (1980) and Smith et al. (I 982a ) demonstrated that intravenous 6-0HDA treatment in an amount sim ilar to that used in the present study produces a complete depletion of CA in the internal layer and an almost complete depletion in the external layer of the median eminence within 24 h. These authors found a substantial return of the CA fluorescence in the external layer by day 7 post injection but not until day 21 was there a strong CA fluorescence in the internal layer of the median eminence.
The dopamine (DA) terminals are found predomi nantly in the external layer of the median emi nence, while the NA terminals are confined mainly to the internal layer (Lofstrom et aI., 1976; Day and Willoughby, 1980) . The DA innervation originates via the tuberoinfundibular system from the arcuate and peri ventricular nuclei (Jonsson et aI., 1972; Bjorklund et aI., 1973) . The median eminence has both a sympathetic innervation (Gallardo et aI., 1984) and a central supply of N A terminals from the lower brainstem as shown by lesioning experiments (Jonsson et aI., 1972; Lofstrom et aI., 1976; Pal kovits et aI., 1977) .
Intravenous 6-0HDA treatment also produces a depletion of the CA fibers of the intermediate and posterior lobe of the pituitary that seems to be more longlasting than that in the median eminence (Baumgarten et aI., 1972; Lim et aI., 1984) .
The stalk transection destroys both the central NA and DA innervation of the posterior and inter mediate lobe of the pituitary in addition to dam aging the portal veins to the anterior lobe. The sym-pathetic fibers from the superior cervical ganglion to the posterior lobe are not affected (Saavedra, 1985) .
The surgical lesion of the median eminence de stroys the central NA-and DA-containing terminals and disrupts the portal system of the median emi nence. The electrothermic lesion produces destruc tion of the same structures encompassed by the surgical lesion, but also damages the arcuate nu cleus in the mediobasal hypothalamus. The in crease in plasma prolactin levels seen in the present study and in previous investigations (Bishop et aI., 1972; Weisenberg et aI., 1979) verifies that there is a damage of the DA terminals in the median emi nence since DA tonically suppresses the prolactin secretion from the anterior lobe of the pituitary (McCann et aI., 1979) .
The absence of spasm in the 6-0HDA-treated animals is not likely to be due just to the damage to the sympathetic system. In separate experiments in animals with cranial sympathectomy prior to an SAH, we found that both acute and late spasm de veloped, although the degree of late spasm was re duced by �50% (Svendgaard et aI., 1985b) . The latter study indicates that the sympathetic system participates in the development of late spasm. The reason Why-despite an intact sympathetic system -lesions of ascending CA pathways in the mesen cephalon and medulla oblongata (Svendgaard et aI., 1985a) prevent the development of spasm could be that the afferent information from the cerebral vessels relayed in these pathways does not reach the autonomic center in the hypothalamus.
The present study demonstrates that the median eminence is a site co-responsible for vasospasm. The results further indicate that it is the NA ter minals within the median eminence that are essen tial for the spasm development. It is unlikely that the DA fibers in the median eminence are involved since they have a high resistance to 6-0HDA (J onsson et aI., 1972; Cuello et aI., 1974) owing probably to the lack of a high-affinity uptake system (Demarest and Moore, 1979) . This is re flected in the rapid reappearance of the DA fluores cence in the median eminence after 6-0HDA treat ment as opposed to the NA fluorescence that does not return until after 3 weeks (Day and Willoughby, 1980; Smith et aI., 1982a) . In addition, the DA mechanisms of the median eminence seem not to be functionally impaired as shown by the normal plasma level of prolactin in 6-0HDA-treated an imals (Day and Willoughby, 1980; Smith et aI., 1982b) . Furthermore, in two animals with lesions placed in the arcuate nuclei, which are the source of the DA innervation of the median eminence, spasm still developed to a normal extent. Finally, 3 weeks after the 6-0HDA treatment, which is the time point when the NA fibers reappear in the me dian eminence, the animals again develop spasm after an SAH (unpublished observation).
The ascending NA pathways from the medulla oblongata are suggested to relay interoceptive sen sory signals to the hypothalamus for the coordina tion of autonomic and endocrine responses (Hansen et aI. , 1981; Sawchenko and Swanson, 198 1; Iversen, 1984) . The NA fibers from the lower brainstem project to the median eminence directly (Palkovits et aI. , 1977) and also to the hypothalamic nuclei (Lindvall and Bjorklund, 1983) that produce the neuropeptides released in or traversing the me dian eminence (Palkovits, 1982) . The neuropeptides include releasing or inhibiting hormones (lutein izing hormone releasing hormone, thyrotropin re leasing hormone, somotostatin), posterior lobe hor mones (vasopressin, oxytocin), and other peptides such as endorphins, enkephalins, adrenocortico tropin, melanocyte-stimulating hormone, and cho lecystokinin (Wood, 1982) .
Generally the NA neurons that terminate in the median eminence facilitate the release of neuropep tides (Fuxe et ai., [976, 1977; Sarkar et ai. , [981) . The neuropeptides in the median eminence may be transported to the pituitary or liberated into the CSF of the third ventricle or the subarachnoid space (Knigge et aI. , [976; Bergland and Page, 1978) . In addition, the peptides can be transported back into the brain by a retrograde capillary flow from the pituitary to the median eminence-brain or via a retrograde axonal transport (Oliver et ai. , 1977; Dorsa et ai., 1979; Palkovits, 1982) . The pos sibility that a substance liberated into the CSF from the median eminence could be involved in the pro duction of spasm led us to examine CSF from both humans and afflicted rats with an SAH. We found a hitherto-unknown spasmogenic compound that is probably a peptide. The compound appears at the same position in the chromatogram (high perfor mance liquid chromatography) of the CSF from both humans and rats with an SAH (to be pub lished).
In conclusion, our study indicates that the me dian eminence is essential in the development of vasospasm post SAH. Whether the median emi nence produces vasospasm via a humoral, neural, or combined neural-humoral mechanism remains to be investigated.
